Patent Assignment
Reel/Frame 059983/0987
Assignment of Assignor's Interest
Recorded: 2022-05-23
Pages: 5
Assignor
CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
Executed: 2021-06-02
Assignee
CELLULAR BIOMEDICINE GROUP HK LIMITED
ROOM 417, 4TH FLOOR, LIPPO CENTRE, TOWER TWO, NO.89 QUEENSWAY, ADMIRALTY, HONG KONG, CHINA
Covered Property
(1)
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 23, 2022
From: YAO, YIHONG; HUANG, JIAQI; ZHU, SHIGUI; ZHU, WEI
To: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.; CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
Reel/Frame 059983/0711 →
Assignment of Assignor's Interest
May 23, 2022
From: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 059983/0801 →
Assignment of Assignor's Interest
Dec 15, 2022
From: CELLULAR BIOMEDICINE GROUP HK LTD.
To: CELLULAR BIOMEDICINE GROUP INC.
Reel/Frame 062105/0405 →
Change of Name
Jan 19, 2024
From: CELLULAR BIOMEDICINE GROUP, INC.
To: ABELZETA INC.
Reel/Frame 066356/0108 →